Intradermal Influenza Vaccine Administered Using a New Microinjection System Produces Superior Immunogenicity in Elderly Adults: A Randomized Controlled Trial

Cited by (254)

Items 101–200 of 254

1. Challenges in the Vaccination of the Elderly and Strategies for Improvement
   Gatot Soegiarto, Dewajani Purnomosari · 2023 · Pathophysiology
2. Comparison of the Immunogenicity and Safety of the Conventional Subunit, MF59-Adjuvanted, and Intradermal Influenza Vaccines in the Elderly
   Yu Bin Seo, Won Suk Choi, Jacob Lee, Joon Young Song, Hee Jin Cheong, Woo Joo Kim · 2014 · Clinical and Vaccine Immunology
3. Intradermal influenza vaccine and new devices: a promising chance for vaccine improvement
   Filippo Ansaldi, Paolo Durando, Giancarlo Icardi · 2011 · Expert Opinion on Biological Therapy
4. Vaccination with influenza hemagglutinin-loaded ceramic nanoporous microneedle arrays induces protective immune responses
   Bert Schepens, Pieter Jan Vos, Xavier Saelens, Koen van der Maaden · 2019 · European Journal of Pharmaceutics and Biopharmaceutics
5. A new approach to estimate vaccine efficacy based on immunogenicity data applied to influenza vaccines administered by the intradermal or intramuscular routes
   Laurent Coudeville, Philippe André, Fabrice Bailleux, Françoise Weber, Stanley Alan Plotkin · 2010 · Human Vaccines
6. Cutaneous delivery of prophylactic and therapeutic vaccines: historical perspective and future outlook
   John A. Mikszta, Philippe E. Laurent · 2008 · Expert Review of Vaccines
7. Prevention of infectious diseases in older adults through immunization: the challenge of the senescent immune response
   Janet E. McElhaney · 2009 · Expert Review of Vaccines
8. Innate gene signature distinguishes humoral versus cytotoxic responses to influenza vaccination
   Eléna Gonçalves, Olivia Bonduelle, Angèle Soria, Pierre Loulergue, Alexandra Rousseau, Marine Cachanado, Henri Bonnabau, Rodolphe Thiébaut, Nicolas Tchitchek, Sylvie Behillil et al. · 2019 · Journal of Clinical Investigation
9. Cross-protection against drifted influenza viruses
   Andrea Orsi, Filippo Ansaldi, Daniela de Florentiis, Antonella Ceravolo, Valentina Parodi, Paola Canepa, Martina Coppelli, Giancarlo Icardi, Paolo Durando · 2013 · Human Vaccines & Immunotherapeutics
10. Influenza vaccines provide diminished protection but are cost‐saving in older adults
    Gregory D. Deans, H Grant Stiver, Janet E. McElhaney · 2009 · Journal of Internal Medicine
11. Review of Influenza Virus Vaccines: The Qualitative Nature of Immune Responses to Infection and Vaccination Is a Critical Consideration
    Lily Chan, Kasra Alizadeh, Kimia Alizadeh, Fatemeh Fazel, Julia E. Kakish, Negar Karimi, Jason P. Knapp, Yeganeh Mehrani, Jessica A. Minott, Solmaz Morovati et al. · 2021 · Vaccines
12. Superior immunogenicity of seasonal influenza vaccines containing full dose of MF59®adjuvant
    Giovanni Della Cioppa, Uwe Nicolay, KELLY A. LINDERT, Geert G Leroux-Roels, Frédéric Clément, Flora Castellino, Grazia Galli, Nicola Groth, Giuseppe Del Giudice · 2012 · Human Vaccines & Immunotherapeutics
13. Vacunación antigripal. Efectividad de las vacunas actuales y retos de futuro
    Raúl Ortíz de Lejarazu, Sonia Tamames · 2015 · Enfermedades Infecciosas y Microbiología Clínica
14. Microneedle and mucosal delivery of influenza vaccines
    Sang‐Moo Kang, Jae-Min Song, Yeu‐Chun Kim · 2012 · Expert Review of Vaccines
15. Immunologic correlates of protection and potential role for adjuvants to improve influenza vaccines in older adults
    Janet E. McElhaney, Rhea N. Coler, Susan L. Baldwin · 2013 · Expert Review of Vaccines
16. Laser vaccine adjuvant for cutaneous immunization
    Xinyuan Chen, Mei X. Wu · 2011 · Expert Review of Vaccines
17. Intradermally-administered influenza virus vaccine is safe and immunogenic in healthy adults 18–64 years of age
    Geoffrey J. Gorse, Ann Regina Falsey, John A. Fling, Terry L. Poling, Cynthia Becher Strout, Peter H. Tsang · 2013 · Vaccine
18. Immunogenicity and safety of low dose virosomal adjuvanted influenza vaccine administered intradermally compared to intramuscular full dose administration
    Valérie Künzi, Jaco M. Klap, Michael Seiberling, Christian Herzog, Katharina Hartmann, Oliver Kürsteiner, Ronald Kompier, Roberto Grimaldi, Jaap Goudsmit · 2009 · Vaccine
19. Changes in Human Langerhans Cells Following Intradermal Injection of Influenza Virus-Like Particle Vaccines
    Marc Pearton, Sang‐Moo Kang, Jae Min Song, Alexander V. Anstey, Matthew O. Ivory, Richard W. Compans, James C. Birchall · 2010 · PLoS ONE
20. A randomized control trial comparing immunogenicity, safety, and preference for self- versus nurse-administered intradermal influenza vaccine
    Brenda L. Coleman, Allison McGeer, Scott A. Halperin, Joanne Marie Langley, Yassein Shamout, Anna Taddio, Vibhuti S Shah, Shelly McNeil · 2012 · Vaccine
21. Fluzone®Intradermal vaccine: a promising new chance to increase the acceptability of influenza vaccination in adults
    Filippo Ansaldi, Daniela de Florentiis, Paolo Durando, Giancarlo Icardi · 2011 · Expert Review of Vaccines
22. Head-to-head comparison of an intradermal and a virosome influenza vaccine in patients over the age of 60
    Filippo Ansaldi, Andrea Orsi, Daniela de Florentiis, Valentina Parodi, Emanuela Rappazzo, Martina Coppelli, Paolo Durando, Giancarlo Icardi · 2013 · Human Vaccines & Immunotherapeutics
23. Vaccines for the Elderly
    Giuseppe Del Giudice, Birgit Weinberger, Beatrix Grubeck‐Loebenstein · 2014 · Gerontology
24. Factors influencing the immunogenicity of influenza vaccines
    Simin Wen, Zhengyu Wu, Shuyi Zhong, Li Mao, Yuelong Shu · 2021 · Human Vaccines & Immunotherapeutics
25. A dose-ranging study in older adults to compare the safety and immunogenicity profiles of MF59®-adjuvanted and non-adjuvanted seasonal influenza vaccines following intradermal and intramuscular administration
    Giovanni Della Cioppa, Uwe Nicolay, KELLY A. LINDERT, Geert G Leroux-Roels, Frédéric Clément, Flora Castellino, Cristina Galli, Nicola Groth, Yotam Levin, Giuseppe Del Giudice · 2014 · Human Vaccines & Immunotherapeutics
26. Vaccine strategies to enhance immune responses in the aged
    Julie S. Lefebvre, Laura Haynes · 2013 · Current Opinion in Immunology
27. Intanza® 15mcg intradermal influenza vaccine elicits cross-reactive antibody responses against heterologous A(H3N2) influenza viruses
    Filippo Ansaldi, Paola Canepa, Antonella Ceravolo, Laura Valle, Daniela de Florentiis, Raymond P. Oomen, Frederick R. Vogel, Martine Denis, Sandrine Samson, Giancarlo Icardi · 2012 · Vaccine
28. Immunogenicity and safety of intradermal versus intramuscular route of influenza immunization in infants less than 6 months of age: A randomized controlled trial
    Susan Shui Seng Chiu, Kwok‐Hung Chan, Wenwei Tu, YL Lau, Malik J. S. Peiris · 2009 · Vaccine
29. Adenoviral vectors as novel vaccines for influenza
    Lynda Coughlan, Caitlin E. Mullarkey, Sarah C. Gilbert · 2015 · Journal of Pharmacy and Pharmacology
30. The Immune System in the Elderly: A Fair Fight Against Diseases?
    Anis Larbi, Paulina Dominika Rymkiewicz, Anusha Vasudev, Ivy Low, Nurhidaya Binte Shadan, Seri Mustafah, Shamini Ayyadhury, Tamàs Fülöp · 2013 · Aging Health
31. Seasonal influenza immunisation: Strategies for older adults
    William Schaffner, Paul G Van Buynder, Shelly McNeil, Albert D. M. E. Osterhaus · 2018 · International Journal of Clinical Practice
32. Clinical studies assessing immunogenicity and safety of intradermally administered influenza vaccines
    Vanessa Vankerckhoven, Pierre Van Damme · 2010 · Expert Opinion on Drug Delivery
33. Microarray patches: scratching the surface of vaccine delivery
    Jovin J. Y. Choo, Christopher L. D. McMillan, Paul R. Young, David Alexander Muller · 2023 · Expert Review of Vaccines
34. The immunogenicity of intradermal influenza vaccination in COPD patients
    Benjamas Chuaychoo, Phunsup Wongsurakiat, Arth Nana, Uraiwan Kositanont, Khun Nanta Maranetra · 2010 · Vaccine
35. Technologies to Improve Immunization
    Mark J. Papania, Darin Zehrung, Courtney Jarrahian · 2017 · Elsevier eBooks
36. Acceptance and Opinions of Intanza/IDflu Intradermal Influenza Vaccine in the Czech Republic and Turkey
    Roman Prymula, Gaye Usluer, Serdar Altınel, Radka Sichova, Françoise Weber · 2012 · Advances in Therapy
37. Inactivated Influenza Vaccines
    Joseph Bresee, Alicia M. Fry, Suryaprakash R. Sambhara, Nancy J. Cox · 2017 · Elsevier eBooks
38. Intradermal Vaccination to Protect Against Yellow Fever and Influenza
    Anna H.E. Roukens, Luc B. S. Gelinck, Leo G. Visser · 2011 · Current topics in microbiology and immunology
39. Vaccine-preventable diseases: From paediatric to adult targets
    Susanna Esposito, Paolo Durando, Samantha Bosis, Filippo Ansaldi, Claudia Tagliabue, Giancarlo Icardi · 2014 · European Journal of Internal Medicine
40. Antibody responses to intradermal or intramuscular MF59-adjuvanted influenza vaccines as evaluated in elderly institutionalized volunteers during a season of partial mismatching between vaccine and circulating A(H3N2) strains
    Barbara Camilloni, Michela Basileo, Angela Di Martino, Isabella Donatelli, Anna Maria Iorio · 2014 · Immunity & Ageing
41. Intradermal vaccination with un-adjuvanted sub-unit vaccines triggers skin innate immunity and confers protective respiratory immunity in domestic swine
    Jean-Benoît Le Luduec, Sabine O.S. Debeer, Fabienne Piras, Christine Andréoni, Florence Boudet, Philippe E. Laurent, Dominique Kaiserlian, Bertrand Dubois · 2016 · Vaccine
42. Microneedle delivery of trivalent influenza vaccine to the skin induces long-term cross-protection
    Yeu‐Chun Kim, Su‐Hwa Lee, Won‐Hyung Choi, Hyo‐Jick Choi, Tae‐Won Goo, Juhie Lee, Fu‐Shi Quan · 2016 · Journal of drug targeting
43. Immune responses to intradermal and intramuscular inactivated influenza vaccine among older age group
    Kobporn Boonnak, Jittima Dhitavat, Narumon Thantamnu, Nathamon Kosoltanapiwat, Montida Auayporn, Li Jiang, Pilaipan Puthavathana, Punnee Pitisuttithum · 2017 · Vaccine
44. Serum 25-Hydroxyvitamin D Level and Influenza Vaccine Immunogenicity in Children and Adolescents
    Michelle E. Science, Jonathon L. Maguire, Margaret L. Russell, Marek Smieja, Stephen D. Walter, Mark B Loeb · 2014 · PLoS ONE
45. Influenza Vaccination in the Elderly: Seeking New Correlates of Protection and Improved Vaccines
    Janet E. McElhaney · 2008 · Aging Health
46. Vaccine responsiveness in the elderly: best practice for the clinic
    Richard Aspinall, Pierre Olivier Lang · 2014 · Expert Review of Vaccines
47. Intradermal travel vaccinations-when less means more
    Frieder Schaumburg, Cornelis Adrianus De Pijper, Martin P. Grobusch · 2019 · Travel Medicine and Infectious Disease
48. Development and psychometric validation of a self-administered questionnaire assessing the acceptance of influenza vaccination: the Vaccinees' Perception of Injection (VAPI©) questionnaire
    Catherine Chevat, Muriel Viala-Danten, Carla Dias-Barbosa, Van Hung Nguyen · 2009 · Health and Quality of Life Outcomes
49. Acceptance and Safety of the Intradermal Influenza Vaccine Among the Elderly in Italy: an On-Field National Study
    The Italian Intradermal Influenza Vaccine Working Group, Paolo Durando, Cristiano Alicino, Marisa Alberti, Laura Sticchi, Valter Turello, Lorenzo Marensi, Anna Luisa Caiazzo, Maria Grazia Panico, Francesco Giugliano et al. · 2012 · Advances in Therapy
50. An Update on the Application of Physical Technologies to Enhance Intradermal and Transdermal Drug Delivery
    Anushree Herwadkar, Ajay K. Banga · 2012 · Therapeutic Delivery
51. Direct Comparison of an Inactivated Subvirion Influenza A Virus Subtype H5N1 Vaccine Administered by the Intradermal and Intramuscular Routes
    Shital M. Patel, Robert L. Atmar, Hana M. El Sahly, K. Guo, Heather Hill, W Keitel · 2012 · The Journal of Infectious Diseases
52. Superior immunogenicity profile of the new intradermal influenza vaccine compared to the standard subcutaneous vaccine in subjects 65 years and older: A randomized controlled phase III study
    Ryo Arakane, Ryosuke Annaka, Akiko Takahama, Katsuyasu Ishida, Michiharu Yoshiike, Tetsuo Nakayama, Fumihiko Takeshita · 2015 · Vaccine
53. Age- and risk-related appropriateness of the use of available influenza vaccines in the Italian elderly is advantageous: results from a budget impact analysis
    Barbieri, Marco, Stefano Capri, C de Waure, Boccalini, Sara, Donatella Panatto · 2017 · Journal of preventive medicine and hygiene
54. Understanding and improving vaccine efficacy in older adults
    Sebastian J. Hofer, Simon Rapp, Paul Klenerman, Anna Katharina Simon · 2025 · Nature Aging
55. Intradermal and virosomal influenza vaccines for preventing influenza hospitalization in the elderly during the 2011–2012 influenza season: A comparative effectiveness study using the Valencia health care information system
    Joan Puig‐Barberà, Angels Natividad-Sancho, J. Calabuig-Pérez, José Antonio Lluch Rodrigo, Eliseo Pastor-Villalba, Sergio Martínez-Úbeda, Javier Díez‐Domingo · 2014 · Vaccine
56. Immunosenescence: implications for vaccination programs in the elderly
    Dawn M. E. Bowdish, Dessi Loukov, Avee Naidoo · 2015 · Vaccine Development and Therapy
57. Immunogenicity and safety of Intanza®/IDflu®intradermal influenza vaccine in South Korean adults: A multicenter, randomized trial
    Sang Hoon Han, Jun Hee Woo, Françoise Weber, Woo Joo Kim, Kyong Ran Peck, Sang-Il Kim, Young Hwa Choi, June Myung Kim · 2013 · Human Vaccines & Immunotherapeutics
58. Non-invasive transcutaneous influenza immunization using vaccine-loaded vaterite particles
    Yulia I. Svenskaya, Екатерина Владимировна Ленгерт, Yana V. Tarakanchikova, Albert Radikovich Muslimov, Мariia S. Saveleva, Elina Alekseevna Genina, Igor L. Radchenko, Liudmila A. Stepanova, Andrey V. Vasin, Gleb B. Sukhorukov et al. · 2023 · Journal of Materials Chemistry B
59. Randomized Controlled Trial to Compare Immunogenicity of Standard-Dose Intramuscular Versus Intradermal Trivalent Inactivated Influenza Vaccine in HIV-Infected Men Who Have Sex With Men in Bangkok, Thailand
    Shikha Garg, Prasert Thongcharoen M. D, Prabda Praphasiri, Anupong Chitwarakorn, Pornchai Sathirapanya, Stefan Fernandez, Kamonthip Rungrojcharoenkit, Wannee Chonwattana, Philip A. Mock, Wichuda Sukwicha et al. · 2015 · Clinical Infectious Diseases
60. Perspectives on vaccine development for the elderly
    Ernesto Oviedo‐Orta, Chris Ka-fai Li, Rino Rappuoli · 2013 · Current Opinion in Immunology
61. Acceptability of Intanza® 15 μg intradermal influenza vaccine in Belgium during the 2010–2011 influenza season
    P. Dhont, Adelin Albert, Patrick Brenders, Anna Podwapinska, Ann Pollet, Dirk Scheveneels, François Tihon, Ilse Verheyden, Jan Victor, Sandrine Samson · 2012 · Advances in Therapy
62. Review of recent literature on microneedle vaccine delivery technologies
    Anto Vrdoljak · 2013 · Vaccine Development and Therapy
63. Immunogenicity and Safety of Intradermal Influenza Vaccine in the Elderly: A Meta-Analysis of Randomized Controlled Trials
    Claudia Pileggi, Valentina Mascaro, Aida Bianco, Carmelo Giuseppe Angelo Nobile, María Pavía · 2015 · Drugs & Aging
64. Immunogenicity and safety of the new intradermal influenza vaccine in adults and elderly: A randomized phase 1/2 clinical trial
    Ryo Arakane, Hitomi Nakatani, Emi Fujisaki, Akiko Takahama, Katsuyasu Ishida, Michiharu Yoshiike, Tetsuo Nakayama, Fumihiko Takeshita · 2015 · Vaccine
65. Performance and usability evaluation of novel intradermal injection device Immucise™ and reanalysis of intradermal administration trials of influenza vaccine for the elderly
    Sakiko Shimizu, Ryo Tanaka, Eriko Itoh, Minami Maekawa-Matsuura, Yoichiro Iwase · 2022 · Vaccine
66. Enhancing Immunogenicity of Influenza Vaccine in the Elderly through Intradermal Vaccination: A Literature Analysis
    Huy Quang Quach, Richard B. Kennedy · 2022 · Viruses
67. A noninflammatory immune response in aged DNA Aβ42-immunized mice supports its safety for possible use as immunotherapy in AD patients
    Doris Lambracht‐Washington, Roger N. Rosenberg · 2014 · Neurobiology of Aging
68. Fluzone® Intradermal Quadrivalent Influenza Vaccine
    Corwin A. Robertson, Peter H. Tsang, Victoria A. Landolfi, David P. Greenberg · 2016 · Expert Review of Vaccines
69. Intanza® 15 μg Intradermal Seasonal Influenza Vaccine
    Sean T. Duggan, Greg L. Plosker · 2010 · Drugs & Aging
70. Evaluation of Microneedles in Human Subjects
    Haripriya Kalluri, Seong‐O Choi, Xin Dong Guo, Jeong Woo Lee, James J. Norman, Mark R. Prausnitz · 2017 · Springer eBooks
71. Alternative Vaccination Routes against Paratuberculosis Modulate Local Immune Response and Interference with Tuberculosis Diagnosis in Laboratory Animal Models
    Rakel Arrazuria, Iraia Ladero-Auñon, Elena Molina, M. Fuertes, Ramón Antonio Juste, Miguel Fernández, Valentín Pérez Pérez, Joseba M. Garrido, Natalia Elguezábal · 2020 · Veterinary Sciences
72. Routes of Delivery for Biological Drug Products
    Darrell J. Irvine, Xingfang Su, Brandon Kwong · 2013 · Wiley eBooks
73. Immunogenicity and Safety of Intradermal Trivalent Influenza Vaccination in Nursing Home Older Adults: A Randomized Controlled Trial
    Tuen‐Ching Chan, Ivan Fan‐Ngai Hung, Kwok‐Hung Chan, Clara Pui-Yan Li, Patrick Tsz-Wai Li, James Ka-Hay Luk, Leung‐Wing Chu, Felix Hon-Wai Chan · 2014 · Journal of the American Medical Directors Association
74. New emerging technologies and the intradermal route: the novel way to immunize against influenza
    Ann Regina Falsey · 2010 · Vaccine
75. Improving seasonal and pandemic influenza vaccines
    Melanie K. Saville, Grenville Marsh, Agnès Hoffenbach · 2008 · Influenza and Other Respiratory Viruses
76. Assessing the safety of influenza vaccination in specific populations: children and the elderly
    Ali Rowhani‐Rahbar, Nicola P. Klein, Roger P. Baxter · 2012 · Expert Review of Vaccines
77. Study of the Immune Response in the Elderly: Is It Necessary to Develop a Vaccine againstNeisseria meningitidisfor the Aged?
    Gabriela Trzewikoswki de Lima, Elizabeth De Gaspari · 2019 · Journal of Aging Research
78. Strategies to Improve the Effect of Vaccination in the Elderly: the Vaccine Producer's Perspective
    B. Guy · 2009 · Journal of Comparative Pathology
79. Targeted Vaccine Selection in Influenza Vaccination
    Peter Wutzler, Roland Hardt, Markus Knuf, Klaus Wahle · 2013 · Deutsches Ärzteblatt international
80. The intradermal vaccination route – an attractive opportunity for influenza vaccination in the elderly
    Marc Paccalin, Birgit Weinberger, Jean‐François Nicolas, Pierre Van Damme, Yves Mégard · 2010 · European Geriatric Medicine
81. Resumen ejecutivo del documento de actualización y reflexión sobre vacunación antigripal en España
    A. García, María Fernández-Prada, Javier Arı́stegui, Daniel Moreno, Esther Redondo, Isabel Jimeno, Manuel Garcìa Cenoz, José Antonio López Trigo · 2018 · Vacunas
82. The convergent evolution of influenza A virus: Implications, therapeutic strategies and what we need to know
    Zheng Yao Low, Ka Heng Wong, Ashley Jia Wen Yip, Wee Sim Choo · 2023 · Current Research in Microbial Sciences
83. Skin Vaccination Methods: Gene Gun, Jet Injector, Tattoo Vaccine, and Microneedle
    Yeu‐Chun Kim · 2017 · Springer eBooks
84. Seasonal trivalent inactivated influenza vaccine with topical imiquimod in immunocompromised patients: A randomized controlled trial
    Matteo Mombelli, Katja Höschler, Matthias L. Cavassini, Manuel A. Pascual, Oriol Manuel · 2021 · Journal of Infection
85. Preclinical evaluation of Vaxfectin®-adjuvanted Vero cell-derived seasonal split and pandemic whole virus influenza vaccines
    Larry R Smith, Walter Wodal, Brian A. Crowe, Astrid Kerschbaum, Peter Bruehl, Michael G. Schwendinger, Helga Savidis-Dacho, Seán M. Sullivan, Mark Shlapobersky, Jukka Hartikka et al. · 2013 · Human Vaccines & Immunotherapeutics
86. Vacunación antigripal en personas mayores
    Gloria Mato Chaín, Alberto Mariano Lázaro, Florentina Alcudia Pérez, Carlos Verdejo Bravo · 2011 · Revista Española de Geriatría y Gerontología
87. Triggering of Toll-like Receptors in Old Individuals. Relevance for Vaccination
    Nahid Zareian, Stefano Aprile, Laura Cristaldi, Mattia Emanuela Ligotti, Sonya Vasto, Farzin Farzaneh · 2019 · Current Pharmaceutical Design
88. The Imperative of Influenza Vaccines for Elderly Individuals—An Evolving Story
    Gregory A. Poland, Mark J. Mulligan · 2009 · The Journal of Infectious Diseases
89. A Comprehensive Design-to-skin Pipeline to Fabricate Polymeric Microneedles Using Ultrahigh-resolution 3D Printing
    Francesco La Malfa, Isabella A. van Hulst, FERRY A. OSSENDORP, U. Staufer, Koen van der Maaden · 2025 · Pharmaceutical Research
90. A Smart Interface for Reliable Intradermal Injection and Infusion of High and Low Viscosity Solutions
    Michael Vosseler, Michael Jugl, Roland Zengerle · 2010 · Pharmaceutical Research
91. Allergen-specific immunotherapy of allergy and asthma: current and future trends
    François Spertini, Christophe Reymond, Annette Leimgruber · 2009 · Expert Review of Respiratory Medicine
92. Original antigenic sin: A potential double-edged effect for vaccine improvement
    Xuan Ding, Feijun Zhao, Zhaoping Liu, Jiangchen Yao, Han Yu, Xiaohong Zhang · 2024 · Biomedicine & Pharmacotherapy
93. Comparison of immunogenicity between intradermal and intramuscular injections of repeated annual identical influenza virus strains post-pandemic (2011-2012) in COPD patients
    Benjamas Chuaychoo, Uraiwan Kositanont, Parichat Niyomthong, Nuttapol Rittayamai, Sorachai Srisuma, Kanokwan Rattanasaengloet, Walaiporn Wongsrisakunkaew, Julalux Thongam, Thaweesak Songserm · 2019 · Human Vaccines & Immunotherapeutics
94. Antigen Uptake After Intradermal Microinjection Depends on Antigen Nature and Formulation, but Not on Injection Depth
    Romain Leboux, Pim Schipper, Toni M.M. van Capel, Lily Kong, Koen van der Maaden, Alexander Kros, Wim Jiskoot, Esther C. de Jong, Joke A. Bouwstra · 2021 · Frontiers in Allergy
95. Laser-facilitated epicutaneous immunization of mice with SARS-CoV-2 spike protein induces antibodies inhibiting spike/ACE2 binding
    Sandra Scheiblhofer, Stephan Drothler, Werner Braun, Reinhard Braun, Maximilian Boesch, Richard Weiss · 2021 · Vaccine
96. Microneedle-Mediated Immunization Promotes Lung CD8+ T-Cell Immunity
    Yang Yu, Ji Wang, Mei X. Wu · 2023 · Journal of Investigative Dermatology
97. Long-Term Administration of Wilms Tumor-1 Peptide Vaccine in Combination with Gemcitabine Causes Severe Local Skin Inflammation at Injection Sites
    Atsuko Soeda, Yuriko Morita‐Hoshi, M. Kaida, Takako Wakeda, Yuni Yamaki, Yasushi Kojima, Hideki Ueno, Shunsuke Kondo, Chigusa Morizane, M. Ikeda et al. · 2010 · Japanese Journal of Clinical Oncology
98. Skin thickness in neonates: Implications for intradermal vaccination
    Akihiko Saitoh, Jun Nirei, Takeshi Tanaka, Hisanori Haniu, Takatsugu Sakai, Soichiro Okubo, Harunobu Hirano · 2020 · Vaccine
99. Microneedles enable the development of skin-targeted vaccines against coronaviruses and influenza viruses
    Thuy Trang Nguyen, Thi Thuy Dung Nguyen, Tran Nguyen Minh An, Huy Truong Nguyen, Vo Van Giau · 2021 · Pharmaceutical Development and Technology
100. MICRONEEDLES FOR TRANSDERMAL DRUG DELIVERY IN HUMAN SUBJECTS
     Jyoti Gupta · 2009 · SMARTech Repository (Georgia Institute of Technology)